" /> Azercabtagene Zapreleucel - CISMeF





Preferred Label : Azercabtagene Zapreleucel;

NCIt synonyms : Allogeneic Anti-CD19-CAR T-lymphocytes PBCAR0191; Anti-CD19-CAR Allogeneic T-cells PBCAR0191; Allogeneic Anti-CD19-CAR T-cells PBCAR0191;

NCIt definition : A preparation of allogeneic, off-the-shelf, T-lymphocytes that have been genetically modified using a proprietary synthetic nuclease-based system to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19 (cluster of differentiation 19) with potential immunostimulating and antineoplastic activities. Upon administration, azercabtagene zapreleucel specifically recognize and kill CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen, which is expressed in all B-cell lineage malignancies and normal B-cells.;

UNII : PFZ3AP93TA;

Molecule name : PBCAR0191;

NCI Metathesaurus CUI : CL938005;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.